Repositioned drugs: integrating intellectual property and regulatory strategies

Drug Repositioning (Bringing New Life to

Drug Repositioning (Bringing New Life to Shelved Assets and Existing Drugs) || Regulatory Considerations and Strategies for Drug Repositioning

✍ Barratt, Michael J.; Frail, Donald E. 📂 Article 📅 2012 🏛 John Wiley & Sons, Inc. 🌐 English ⚖ 175 KB

Drug Repositioning : The Business Case And Current Strategies To Repurpose Shelved Candidates And Marketed Drugs / John Arrowsmith And Richard Harrison -- Opportunities And Challenges Associated With Developing Additional Indications For Clinical Development Candidates And Marketed Drugs / Donald E.

Intellectual property and chirality of d

Intellectual property and chirality of drugs

✍ Israel Agranat; Hava Caner 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 233 KB

Integrating Intellectual Property Rights

Integrating Intellectual Property Rights and Development Policy: Report of the Commission on Intellectual Property Rights, Commission on Intellectual Property Rights September 2002

✍ Keith E. Maskus 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Drug Repositioning (Bringing New Life to

Drug Repositioning (Bringing New Life to Shelved Assets and Existing Drugs) || Computational and Bioinformatic Strategies for Drug Repositioning

✍ Barratt, Michael J.; Frail, Donald E. 📂 Article 📅 2012 🏛 John Wiley & Sons, Inc. 🌐 English ⚖ 625 KB

Drug Repositioning : The Business Case And Current Strategies To Repurpose Shelved Candidates And Marketed Drugs / John Arrowsmith And Richard Harrison -- Opportunities And Challenges Associated With Developing Additional Indications For Clinical Development Candidates And Marketed Drugs / Donald E.

Intertwining Regimes: Trade, Intellectua

Intertwining Regimes: Trade, Intellectual Property and Regulatory Requirements for Pharmaceuticals

✍ Karin Timmermans 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 519 KB

Drug Repositioning (Bringing New Life to

Drug Repositioning (Bringing New Life to Shelved Assets and Existing Drugs) || Business Development Strategies in the Repositioning Industry

✍ Barratt, Michael J.; Frail, Donald E. 📂 Article 📅 2012 🏛 John Wiley & Sons, Inc. 🌐 English ⚖ 76 KB

Drug Repositioning : The Business Case And Current Strategies To Repurpose Shelved Candidates And Marketed Drugs / John Arrowsmith And Richard Harrison -- Opportunities And Challenges Associated With Developing Additional Indications For Clinical Development Candidates And Marketed Drugs / Donald E.